Infinity Pharmaceuticals reported 3.85M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US $ 2.98B 99M
Amgen AMGN:US $ 1.31B 79M
AstraZeneca AZN:LN 2.99B 412M
Bristol Myers Squibb BMY:US $ 1.79B 95M
Cytori Therapeutics CYTX:US $ 1.99M 521K
Eisai 4523:JP 79.76B 5.03B
Eli Lilly And LLY:US $ 1.58B 107.8M
Genocea Biosciences GNCA:US $ 3.88M 149K
Gilead Sciences GILD:US $ 1.18B 173M
GlaxoSmithKline GSK:LN 2.5B 6M
Infinity Pharmaceuticals INFI:US 3.85M 349K
Johnson & Johnson JNJ:US $ 6B 73M
Mirati Therapeutics MRTX:US $ 35.18M 5.57M
Novartis NOVN:VX 3.6B 109M
Pfizer PFE:US $ 2.73B 61M
Seattle Genetics SGEN:US $ 180.28M 15.15M
Tg Therapeutics TGTX:US $ 34.9M 882K
Vascular Biogenics VBLT:US 1.62M 144K
YTE INCY:US $ 190.7M 21.84M